Lifestyle as Therapy in Liver Disease
Jadine Scragg
This feasibility study aims to assess the proposed recruitment strategies in a well-defined patient group with advanced Non-alcoholic fatty liver disease (NAFLD) and will determine whether…
Personalised Nutrition in Non-Alcoholic Fatty Liver Disease (NAFLD): Feasibility of a Nutrigenomic Therapeutic Approach
Laura Haigh
NAFLD is a metabolic liver disease that poses a considerable challenge for 21st century healthcare. This increasingly common cause of liver dysfunction and multi-morbidity demands effective dietetic input…
Stratified medicine in Primary Biliary Cholangitis
Newcastle has led the development and implementation of stratified personalised medicine into normal clinical practice, for the autoimmune liver disease PBC.
Rather than being given a single standard therapy, the…
Chronic Cognitive Impairment in Cholestatic Liver Disease: Impact, Pathogenesis, Treatment and Relevance to Dementia
Principal Investigator: Professor David Jones
To develop the essential tools to allow us to explore the utility of early OCA as a transformative treatment for cholestatic cognitive impairment.
The Study
People normally…
NIHR Award supports physiotherapist Kate Hallsworth’s research career
